Lentiviral Vectors: Introduction

Lentiviral vectors are used as a medium to transfer foreign genetic element into another cell. These vectors are produced from lentivirus, which is defined by its long incubation period and can contaminate dividing and non-dividing cells. Lentiviral are vectors that are descended from the virus, known as human immunodeficiency virus, and used to transport genes in the cells, such as mammalian cells. Such vectors are highly capable vehicles for gene delivery for gene treatments.

Lentiviral vectors are utilized in the treatment of various type diseases including HIV, Alzheimer’s disease and amyotrophic lateral sclerosis, β-thalassemia, sickle cell disease, Metachromatic Leukodystrophy, X-linked Adrenoleukodystrophy, and Wiskott-Aldrich Syndrome

Report Overview:https://www.transparencymarketresearch.com/lentiviral-vectors-marke...

Key Drivers of Global Lentiviral Vectors Market

Increase in research & development expenditure on lentiviral vectors from key market players is a major factor driving the global lentiviral vectors market. Increase in prevalence of diseases such as HIV, Alzheimer’s disease, and amyotrophic lateral sclerosis, β-thalassemia, and sickle cell disease is likely to drive the lentiviral vector market during the forecast period. According to World Health Organization, around 38 million people are living with HIV by globally.

Major market players are focused on inorganic growth strategies such as collaborations and agreements for design and development of new products. For instance, in October 2020, AVROBIO, Inc. signed a worldwide license agreement and a collaborative research funding agreement with The University of Manchester for an investigational lentiviral gene therapy for mucopolysaccharidosis type II (MPS II), or Hunter syndrome. In June 2019, Servier Laboratories signed a collaboration agreement with Yposkesi, Inc. for the development of more novel and innovative vectors.

First-generation lentiviral vectors segment to be highly promising

Based on product type, the global lentiviral vectors market can be segmented into first generation, second generation, and third generation

The first generation lentiviral vector segment accounted for a prominent share of the global lentiviral vectors market in 2019. The segment is expected to dominate the lentiviral vectors market, as it is used in the treatment of various type of diseases. First-generation lentiviral vectors contained a significant portion of the HIV genome, including the gag and pol genes as well as several additional viral proteins.

Request Brochure:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B...

HIV segment to expand significantly

In terms of disease indication, the global lentiviral vectors market can be divided into HIV, β-thalassemia, X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy, and Wiskott-Aldrich Syndrome. HIV was a prominent segment, in terms of revenue, in 2019. It is anticipated to expand significantly during the forecast period.

Increase in number of patients with HIV in developed as well as developing region is likely to drive the segment. According to World Health Organization, around 141,552 people were diagnosed with HIV in Europe in 2018.

Hospitals segment to expand considerably

In terms of end-user, the global lentiviral vectors market can be divided into hospitals, clinics and research institute. The hospitals segment accounted for a prominent share of the market, in terms of revenue, in 2019. It is anticipated to expand considerably during the forecast period. Increase in number of patients with HIV, Alzheimer’s disease, amyotrophic lateral sclerosis, β-thalassemia, and sickle cell disease that visit hospitals is likely to boost the segment during the forecast period.

North America to dominate global lentiviral vectors market

In terms of region, the global lentiviral vectors market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America dominated the global lentiviral vectors market in 2019. It is expected to maintain its leading position during the forecast period. Dominance of the region can be attributed to an increase in patients with major chronic diseases such as HIV, cancer, neurological disorders, hematological disorders, and rising number of research and development programs.

The market in Asia Pacific is projected to expand at a significantly high growth rate during the forecast period, owing to the launch of new products and increase in demand for new treatment options for the treatment of diseases such as HIV, cancer, and Alzheimer’s disease

Key Manufacturers Operating in Global Market

Request For Custom Research:

https://www.transparencymarketresearch.com/sample/sample.php?flag=C...

The global lentiviral vectors market was highly fragmented in 2019. Key manufacturers operating in the global market are:

Thermo Fisher Scientific
Sirion-Biotech GmbH
Vigene Biosciences
OriGene Technologies, Inc.
SignaGen Laboratories
Sino Biological Inc.
Takara Bio Inc.
Cell Biolabs, Inc.
GenTarget Inc.
GENEMEDI
bluebird bio, Inc.

Lentiviral Vectors Market: Research Scope

Lentiviral Vectors Market, by Product Type

First Generation
Second Generation
Third Generation

Lentiviral Vectors Market, by Disease Indication

HIV
β-thalassemia
X-linked Adrenoleukodystrophy
Metachromatic Leukodystrophy
Wiskott-Aldrich Syndrome

Lentiviral Vectors Market, by End-user

Hospitals
Clinics
Research Institutes

Request for covid19 Impact Analysis:

https://www.transparencymarketresearch.com/sample/sample.php?flag=c...

Lentiviral Vectors Market, by Region

North America

S.
Canada
Europe

Germany
K.
France
Italy
Spain
Rest of Europe

Asia Pacific

China
India
Japan
Australia & New Zealand
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East & Africa

GCC Countries
South Africa
Rest of Middle East & Africa

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]  
Website: https://www.transparencymarketresearch.com